Fortaleza Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,630
Closed -$824K 99
2017
Q3
$824K Hold
2,630
1.51% 11
2017
Q2
$714K Buy
2,630
+1,450
+123% +$383K 1.36% 16
2017
Q1
$323K Hold
1,180
0.65% 55
2016
Q4
$335K Sell
1,180
-1,020
-46% -$302K 0.71% 54
2016
Q3
$689K Sell
2,200
-2,045
-48% -$606K 0.96% 42
2016
Q2
$1.03M Sell
4,245
-1,220
-22% -$322K 0.84% 54
2016
Q1
$1.42M Sell
5,465
-7
-0.1% -$1.85K 0.9% 48
2015
Q4
$1.68M Sell
5,472
-1,400
-20% -$402K 1.01% 44
2015
Q3
$2M Hold
6,872
1.41% 26
2015
Q2
$2.78M Buy
6,872
+1,960
+40% +$787K 1.67% 16
2015
Q1
$2.07M Sell
4,912
-60
-1% -$23.6K 1.17% 28
2014
Q4
$1.69M Hold
4,972
0.77% 41
2014
Q3
$1.65M Hold
4,972
0.77% 38
2014
Q2
$1.57M Hold
4,972
0.72% 40
2014
Q1
$1.52M Hold
4,972
0.78% 41
2013
Q4
$1.39M Sell
4,972
-405
-8% -$105K 0.71% 47
2013
Q3
$1.29M Hold
5,377
0.68% 51
2013
Q2
$1.16M Buy
+5,377
New +$1.15M 0.67% 54

Other funds holding BIIB

Fortaleza Asset Management's BIIB Position: Q4 2017 in Review

Fortaleza Asset Management sold out of Biogen (BIIB) in Q4 2017, closing a stake of 2,630 shares — an estimated $824K sold.

Fortaleza Asset Management first reported a position in BIIB in Q2 2013 and held it in 18 quarters. The position peaked at $2.78M in Q2 2015. 1,122 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Fortaleza Asset Management reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Fortaleza Asset Management sold 2,630 Biogen shares in Q4 2017, an estimated $824K.
  • Fortaleza Asset Management first reported a position in Biogen in Q2 2013 and held it in 18 quarters.
  • Fortaleza Asset Management's Biogen position peaked at $2.78M in Q2 2015.
  • 1,122 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Fortaleza Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.